Literature DB >> 20647204

Rituximab in ANCA-associated disease.

Ronald J Falk, J Charles Jennette.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20647204     DOI： 10.1056/NEJMe1004992

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

Review 1.  Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis.

Authors:  J Charles Jennette; Ronald J Falk; Adil H Gasim
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-05       Impact factor: 2.894

Review 2.  Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.

Authors:  J Charles Jennette; Ronald J Falk; Peiqi Hu; Hong Xiao
Journal:  Annu Rev Pathol       Date:  2013-01-24       Impact factor: 23.472

3.  Biologic agents in systemic vasculitis.

Authors:  Charles F Henderson; Philip Seo
Journal:  Int J Clin Rheumtol       Date:  2011

4.  Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).

Authors:  Hans-Peter Tony; Gerd Burmester; Hendrik Schulze-Koops; Mathias Grunke; Joerg Henes; Ina Kötter; Judith Haas; Leonore Unger; Svjetlana Lovric; Marion Haubitz; Rebecca Fischer-Betz; Gamal Chehab; Andrea Rubbert-Roth; Christof Specker; Jutta Weinerth; Julia Holle; Ulf Müller-Ladner; Ramona König; Christoph Fiehn; Philip Burgwinkel; Klemens Budde; Helmut Sörensen; Michael Meurer; Martin Aringer; Bernd Kieseier; Cornelia Erfurt-Berge; Michael Sticherling; Roland Veelken; Ulf Ziemann; Frank Strutz; Praxis von Wussow; Florian M P Meier; Nico Hunzelmann; Enno Schmidt; Raoul Bergner; Andreas Schwarting; Rüdiger Eming; Michael Hertl; Rudolf Stadler; Michael Schwarz-Eywill; Siegfried Wassenberg; Martin Fleck; Claudia Metzler; Uwe Zettl; Jens Westphal; Stefan Heitmann; Anna L Herzog; Heinz Wiendl; Waltraud Jakob; Elvira Schmidt; Klaus Freivogel; Thomas Dörner
Journal:  Arthritis Res Ther       Date:  2011-05-13       Impact factor: 5.156

5.  Improved prognosis in Norwegian patients with glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies.

Authors:  Sanjeevan Sriskandarajah; Knut Aasarød; Steinar Skrede; Thomas Knoop; Anna Varberg Reisæter; Rune Bjørneklett
Journal:  Nephrol Dial Transplant       Date:  2015-02-17       Impact factor: 5.992

Review 6.  Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis.

Authors:  Shivani Shah; Duvuru Geetha
Journal:  Immunotargets Ther       Date:  2015-08-07

Review 7.  Progressive dyspnoea following the treatment of Mycobacterium abscessus infection in an individual with relapsing granulamatosis with polyangitis (Wegener's), complicated by hearing loss requiring cochlear implantation.

Authors:  Senyo K Tagboto; Ajay G Venkatesh
Journal:  BMC Pulm Med       Date:  2012-09-04       Impact factor: 3.317

8.  Clinical features of childhood granulomatosis with polyangiitis (wegener's granulomatosis).

Authors:  Marek Bohm; Maria Isabel Gonzalez Fernandez; Seza Ozen; Angela Pistorio; Pavla Dolezalova; Paul Brogan; Giancarlo Barbano; Claudia Sengler; Marisa Klein-Gitelman; Pierre Quartier; Anders Fasth; Troels Herlin; Maria Teresa R A Terreri; Susan Nielsen; Marion A J van Rossum; Tadej Avcin; Esteban Rodolfo Castell; Ivan Foeldvari; Dirk Foell; Anuela Kondi; Isabelle Koné-Paut; Rolf-Michael Kuester; Hartmut Michels; Nico Wulffraat; Halima Ben Amer; Clara Malattia; Alberto Martini; Nicolino Ruperto
Journal:  Pediatr Rheumatol Online J       Date:  2014-05-26       Impact factor: 3.054

9.  Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.

Authors:  Nicholas R Latimer; Christopher Carroll; Ruth Wong; Paul Tappenden; Michael C Venning; Raashid Luqmani
Journal:  Pharmacoeconomics       Date:  2014-12       Impact factor: 4.981

10.  Ectopic Relapse of Anti-neutrophil Cytoplasmic Antibody-associated Pituitary Vasculitis with No Elevation of Anti-neutrophil Cytoplasmic Antibodies after Renal Remission.

Authors:  Reiko Muto; Koji Inagaki; Naokazu Sato; Tetsuro Sameshima; Yuka Nagakura; Satoshi Baba; Noritoshi Kato; Shoichi Maruyama; Toshiyuki Akahori
Journal:  Intern Med       Date:  2020-08-12       Impact factor: 1.271
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.